Literature DB >> 32510963

Unraveling Cell-Type-Specific Targeted Delivery of Membrane-Camouflaged Nanoparticles with Plasmonic Imaging.

Xiaodong Xie1,2, Xingjie Hu2,3, Qian Li4, Min Yin2, Haiyun Song3, Jun Hu1,5, Lihua Wang1,5, Chunhai Fan4, Nan Chen2.   

Abstract

Cell-membrane-camouflaged nanoparticles (CMC-NPs) have been increasingly exploited to develop various therapeutic tools due to their high biocompatibility and cell-type-specific tumor-targeting properties. However, the molecular mechanism of CMC-NPs for homotypic targeting remains elusive. Here, we develop a plasmonic imaging method by coating gold nanoparticles (AuNPs) with cancer cell membranes and perform plasmonic imaging of the interactions between CMC-NPs and living cells at the single-cell level. Quantitative analysis of CMC-NPs in a different clustering status reveals that the presence of cell membranes on CMC-NPs results in a 7-fold increase in homotypic cell delivery and nearly 2 orders of magnitude acceleration of the intracellular agglomeration process. Significantly, we identify that integrin αvβ3, a cell surface receptor abundantly expressed in tumor cells, is critical for the selective cell recognition of CMC-NPs. We thus establish a single-cell plasmonic imaging platform for probing NP-cell interactions, which sheds new light on the therapeutic applications of CMC-NPs.

Entities:  

Keywords:  AuNPs; Cell-membrane-camouflaged nanoparticles; homotypic targeting; integrin αvβ3; plasmonic imaging

Mesh:

Substances:

Year:  2020        PMID: 32510963     DOI: 10.1021/acs.nanolett.0c01503

Source DB:  PubMed          Journal:  Nano Lett        ISSN: 1530-6984            Impact factor:   11.189


  7 in total

1.  Systematic design of cell membrane coating to improve tumor targeting of nanoparticles.

Authors:  Lizhi Liu; Dingyi Pan; Sheng Chen; Maria-Viola Martikainen; Anna Kårlund; Jing Ke; Herkko Pulkkinen; Hanna Ruhanen; Marjut Roponen; Reijo Käkelä; Wujun Xu; Jie Wang; Vesa-Pekka Lehto
Journal:  Nat Commun       Date:  2022-10-19       Impact factor: 17.694

2.  Erythrocyte membrane-camouflaged nanoparticles as effective and biocompatible platform: Either autologous or allogeneic erythrocyte-derived.

Authors:  Jun Dai; Zhaojun Chen; Shixuan Wang; Fan Xia; Xiaoding Lou
Journal:  Mater Today Bio       Date:  2022-05-05

3.  Effective Triple-Negative Breast Cancer Targeted Treatment Using iRGD-Modified RBC Membrane-Camouflaged Nanoparticles.

Authors:  Jingbin Huang; Wenjing Lai; Qing Wang; Qin Tang; Changpeng Hu; Min Zhou; Fengling Wang; Dandan Xie; Qian Zhang; Wuyi Liu; Zhe Zhang; Rong Zhang
Journal:  Int J Nanomedicine       Date:  2021-11-10

4.  Homotypic targeting of immunomodulatory nanoparticles for enhanced peripheral and central immunity.

Authors:  Yubo Shen; Daoxia Guo; Xiaoyuan Ji; Yanfeng Zhou; Shuo Liu; Jing Huang; Haiyun Song
Journal:  Cell Prolif       Date:  2022-01-27       Impact factor: 6.831

5.  Breast Cancer Cell Membrane Camouflaged Lipid Nanoparticles for Tumor-Targeted NIR-II Phototheranostics.

Authors:  Mengze Xu; Yu Yang; Zhen Yuan
Journal:  Pharmaceutics       Date:  2022-06-28       Impact factor: 6.525

Review 6.  Nanocomposite hydrogels for biomedical applications.

Authors:  Shanghui Huang; Xiangqian Hong; Mingyi Zhao; Nanbo Liu; Huiling Liu; Jun Zhao; Longquan Shao; Wei Xue; Han Zhang; Ping Zhu; Rui Guo
Journal:  Bioeng Transl Med       Date:  2022-04-09

Review 7.  Recent progress in targeted delivery vectors based on biomimetic nanoparticles.

Authors:  Li Chen; Weiqi Hong; Wenyan Ren; Ting Xu; Zhiyong Qian; Zhiyao He
Journal:  Signal Transduct Target Ther       Date:  2021-06-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.